The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)
Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
This study is aimed at identifying the efficacy of Tachosil® for prevention of hemorrhage in
patients with cervical intraepithelial neoplasia or cervical cancer after undergoing a loop
electrosurgical excisional procedure (LEEP).
1. Primary endpoint:
Bleeding period within two weeks after surgery Frequency of additional treatment due to
bleeding within two weeks after surgery
2. Secondary endpoint:
Amount of bleeding within two weeks after surgery Infection frequency at external genitals,
vagina and cervix within two weeks after surgery Change in life quality after surgery